On October 29, 2023, Scott Myers resigned as a member of the board of directors (the "Board") of Viridian Therapeutics, Inc. (the "Company"), effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Scott Myers resigned as director at Viridian Therapeutics, Inc.\DE.
Action
resigned
Role
director
Exact text from the filing
On October 29, 2023, Scott Myers resigned as a member of the board of directors (the "Board") of Viridian Therapeutics, Inc. (the "Company"), effective immediately.
Viridian Therapeutics, Inc.\DE: The Board adopted the Third Amended and Restated Bylaws, modifying the notice period required to call a special meeting of the Board (effective 2023-11-01).
Change
bylaw amendment
Effective
2023-11-01
Exact text from the filing
Effective November 1, 2023, the Board adopted the Third Amended and Restated Bylaws of the Company (the “Bylaws”). The Bylaws, among other things, modify the notice period required to call a special meeting of the Board.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.